Profil
Nigel Ray currently works at Angarus Therapeutics, Inc., as President, Chief Executive Officer & Director from 2019.
Mr. Ray also formerly worked at DURECT Corp., as Director-Business Development in 2009 and Limerick BioPharma, Inc., as Vice President-Business Development in 2009.
Mr. Ray received his undergraduate degree from Stanford University and Masters Business Admin degree from the University of California, Los Angeles.
Aktive Positionen von Nigel Ray
| Unternehmen | Position | Beginn |
|---|---|---|
Angarus Therapeutics, Inc.
Angarus Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides immuno-oncology therapies | Vorstandsvorsitzender | 01.11.2019 |
Ehemalige bekannte Positionen von Nigel Ray
| Unternehmen | Position | Ende |
|---|---|---|
Limerick BioPharma, Inc.
Limerick BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | 01.09.2009 |
| DURECT | Corporate Officer/Principal | 01.01.2009 |
Ausbildung von Nigel Ray
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
DURECT Corp.
DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Limerick BioPharma, Inc.
Limerick BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Angarus Therapeutics, Inc.
Angarus Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides immuno-oncology therapies | Health Services |
















